Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-16-000419
Filing Date
2016-05-23
Accepted
2016-05-23 15:08:34
Documents
22
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 f10qmar312016v4.htm 10-Q 176622
2 exhibit311.htm EX-31 9396
3 exhibit321.htm EX-32 4691
  Complete submission text file 0001551163-16-000419.txt   497470

Data Files

Seq Description Document Type Size
4 prtt-20160331.xml EX-101.INS 19225
5 prtt-20160331.xsd EX-101.SCH 5690
6 prtt-20160331_cal.xml EX-101.CAL 11787
7 prtt-20160331_def.xml EX-101.DEF 3840
8 prtt-20160331_lab.xml EX-101.LAB 44978
9 prtt-20160331_pre.xml EX-101.PRE 32538
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

EIN.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 161668787
SIC: 2834 Pharmaceutical Preparations